Mike Mensinger, Chief Product Officer at Beta Bionics, Inc. (BBNX), sold 7,800 shares at $29.56 ($231K) on 2026-01-02, disclosed to the SEC on 2026-01-05.
Scheduled sale ($231k) by Chief Product Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.56 | 7,200 | $213K | 92.2% |
| 2 | $30.20 | 600 | $18K | 7.8% |
| Total | $29.61 avg | 7,800 | $231K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $55K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $13K | — | Filing → |
| BBNX | SELL | 2026-01-07 | $66K | — | Filing → |